Osseous xanthomatosis and pathologic fractures in familial hyperlipemia (hyperglyceridemia): Observations during chlorophenoxyisobutyrate, estrogen and androgen therapy von Brusco, Osvaldo J., Howard, R.Palmer, Jarman, Joe B., Furman, Robert H.

Volltext

Osseous xanthomatosis and pathologic fractures in familial hyperlipemia (hyperglyceridemia) von Brusco, Osvaldo J., Howard, R.Palmer, Jarman, Joe B., Furman, Robert H.

Volltext

Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial Infarction von Lu, Zongliang, MD, PhD, Kou, Wenrong, MD, Du, Baomin, MD, Wu, Yangfeng, MD, Zhao, Shuiping, MD, PhD, Brusco, Osvaldo A., MD, Morgan, John M., MD, Capuzzi, David M., MD, PhD

Volltext

Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes von Pergola, Pablo E, Raskin, Philip, Toto, Robert D, Meyer, Colin J, Huff, J. Warren, Grossman, Eric B, Krauth, Melissa, Ruiz, Stacey, Audhya, Paul, Christ-Schmidt, Heidi, Wittes, Janet, Warnock, David G

Volltext

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics von Jardine, Meg J., Mahaffey, Kenneth W., Neal, Bruce, Agarwal, Rajiv, Bakris, George L., Brenner, Barry M., Bull, Scott, Cannon, Christopher P., Charytan, David M., de Zeeuw, Dick, Edwards, Robert, Greene, Tom, Heerspink, Hiddo J.L., Levin, Adeera, Pollock, Carol, Wheeler, David C., Xie, John, Zhang, Hong, Zinman, Bernard, Desai, Mehul, Perkovic, Vlado

Volltext

Effects of Xuezhikang in patients with dyslipidemia: A multicenter, randomized, placebo-controlled study von Moriarty, Patrick M., MD, Roth, Eli M., MD, Karns, Adam, MD, Ye, Ping, MD, PhD, Zhao, Shui-Ping, MD, PhD, Liao, Yuhua, MD, Capuzzi, David M., MD, Bays, Harold E., MD, Zhang, Fumin, MD, Liu, Shaowen, MD, Reichman, Alan J., MD, Brusco, Osvaldo A., MD, Lu, Guoping, MD, Lerman, Sam, MD, Duan, Zhenwen, PhD, Guo, Shuren, MD, Liu, Ping Lan, MD, Zhao, Junxian, MD, Zhang, Yan, MD, Li, Simon, MD, PhD

Volltext

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a... von Garber, Alan J, Dr, Prof, King, Allen B, MD, Prato, Stefano Del, Prof, Sreenan, Seamus, MD, Balci, Mustafa K, MD, Muñoz-Torres, Manuel, Prof, Rosenstock, Julio, Prof, Endahl, Lars A, PhD, Francisco, Ann Marie Ocampo, MD, Hollander, Priscilla, MD

Volltext

Niacin dosing: relationship to benefits and adverse effects von Capuzzi, D M, Morgan, J M, Brusco, Jr, O A, Intenzo, C M

Volltext

Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control von Raskin, P, Lewin, A, Reinhardt, R, Lyness, W

Volltext